Differential protein acetylation induced by novel histone deacetylase inhibitors
- 2 November 2004
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 325 (3) , 683-690
- https://doi.org/10.1016/j.bbrc.2004.10.082
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Valproic acid treatment of glioblastoma multiforme in a childPediatric Blood & Cancer, 2004
- Expression and functional characterization of recombinant human HDAC1 and HDAC3Life Sciences, 2004
- α-Keto amides as inhibitors of histone deacetylaseBioorganic & Medicinal Chemistry Letters, 2003
- Tumor cell‐specific cytotoxicity by targeting cell cycle checkpointsThe FASEB Journal, 2003
- Histone deacetylase inhibitors: from target to clinical trialsExpert Opinion on Investigational Drugs, 2002
- Enzymatic Activity Associated with Class II HDACs Is Dependent on a Multiprotein Complex Containing HDAC3 and SMRT/N-CoRMolecular Cell, 2002
- hSIR2SIRT1 Functions as an NAD-Dependent p53 DeacetylasePublished by Elsevier ,2001
- Negative Control of p53 by Sir2α Promotes Cell Survival under StressPublished by Elsevier ,2001
- Chromatin remodeling: why it is important in cancerOncogene, 2001
- The Human Histone Deacetylase FamilyExperimental Cell Research, 2001